Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.8 EUR
569.26 M EUR
1.15 B EUR
272.66 M
About INTERMEDIATE CAPITAL GROUP PLC ORD GBP0.2625
Sector
Industry
CEO
Benoît Laurent P. Durteste
Website
Headquarters
London
Founded
1988
ISIN
GB00BYT1DJ19
FIGI
BBG000Q6Q1B4
Intermediate Capital Group Plc provides flexible capital solutions to help companies develop and grow. It is a global alternative asset manager with over 30 years' history, investing across the capital structure. It operates across four asset classes: Structured and Private Equity, Private Debt, Real Assets, and Credit. The company was founded by Andrew Jackson, Thomas Hugh Bartlam, Jean-Loup Brousse de Gersigny, James Odgers, Andrew Coventon Phillips, and Paul J. Piper on March 23, 1988 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INTERMED.CAP.GRP.LS-,2625 stocks are traded under the ticker I2X2.
We've gathered analysts' opinions on INTERMED.CAP.GRP.LS-,2625 future price: according to them, I2X2 price has a max estimate of 34.26 EUR and a min estimate of 27.65 EUR. Watch I2X2 chart and read a more detailed INTERMED.CAP.GRP.LS-,2625 stock forecast: see what analysts think of INTERMED.CAP.GRP.LS-,2625 and suggest that you do with its stocks.
I2X2 reached its all-time high on May 29, 2024 with the price of 28.6 EUR, and its all-time low was 6.0 EUR and was reached on Mar 19, 2020. View more price dynamics on I2X2 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track INTERMED.CAP.GRP.LS-,2625 financials in yearly and quarterly reports right on TradingView.
INTERMED.CAP.GRP.LS-,2625 is going to release the next earnings report on May 22, 2025. Keep track of upcoming events with our Earnings Calendar.
I2X2 earnings for the last half-year are 0.63 EUR per share, whereas the estimation was 0.98 EUR, resulting in a −36.35% surprise. The estimated earnings for the next half-year are 0.97 EUR per share. See more details about INTERMED.CAP.GRP.LS-,2625 earnings.
INTERMED.CAP.GRP.LS-,2625 revenue for the last half-year amounts to 486.76 M EUR, despite the estimated figure of 588.84 M EUR. In the next half-year revenue is expected to reach 600.22 M EUR.
I2X2 net income for the last half-year is 183.15 M EUR, while the previous report showed 306.04 M EUR of net income which accounts for −40.15% change. Track more INTERMED.CAP.GRP.LS-,2625 financial stats to get the full picture.
INTERMED.CAP.GRP.LS-,2625 dividend yield was 3.85% in 2023, and payout ratio reached 46.45%. The year before the numbers were 6.37% and 78.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 6, 2025, the company has 637.00 employees. See our rating of the largest employees — is INTERMED.CAP.GRP.LS-,2625 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTERMED.CAP.GRP.LS-,2625 EBITDA is 625.72 M EUR, and current EBITDA margin is 60.99%. See more stats in INTERMED.CAP.GRP.LS-,2625 financial statements.
Like other stocks, I2X2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTERMED.CAP.GRP.LS-,2625 stock right from TradingView charts — choose your broker and connect to your account.